As a second-generation Ghanaian American, Ophelia Ardayfio has experienced bias ranging from outright racism to more subtle workplace micro-inequities or micro-aggressions. Beyond her role as a portfolio strategy director in the Chemical Biology & Therapeutics (CBT) functional area, these experiences have motivated her work with Novartis’s employee resource groups (ERGs) to help the company become more equitable and inclusive.

By K.E.D. Coan

Published on 18/06/2022